FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002104731> ?p ?o ?g. }

• W2002104731 endingPage "1414" @default.
• W2002104731 startingPage "1405" @default.
• W2002104731 abstract "Objectives: The K65R mutation in HIV-1 reverse transcriptase (RT) decreases susceptibility to all approved nucleoside reverse transcriptase inhibitors (NRTI) except zidovudine by selectively decreasing the incorporation of the NRTI triphosphate compared with the natural deoxyribonucleotide triphosphate substrate. Thymidine analog mutations (TAMs) confer high-level resistance to zidovudine and cross-resistance to other NRTI by increasing excision of the chain-terminating NRTI monophosphate via a phosphorolytic cleavage reaction. Recent virology and genetic studies have shown bidirectional antagonism between K65R and TAMs. The aim of this study was to elucidate the biochemical and structural mechanisms responsible for this antagonism. Methods: Steady-state and pre-steady-state kinetic analyses of NRTI triphosphate incorporation and NRTI monophosphate excision by RT containing K65R or TAMs were conducted and complemented by molecular modeling. Results: The addition of K65R to two clinically relevant combinations of TAMs (M41L/L210W/T215Y or D67N/K70R/T215F/K219Q) significantly reduced the recombinant enzymes' ability to excise all chain-terminating NRTI monophosphate. Transient kinetic analyses showed that TAMs decreased the extent to which RT containing K65R could discriminate against D-nucleotide analogs, but not L-nucleotide analogs, by partly restoring the maximum rate of NRTI triphosphate incorporation. In addition, the TAMs combination D67N/K70R/T215F/K219Q decreased susceptibility to the L-nucleotide lamivudine by a discrimination mechanism, whereas the M41L/L210W/T215Y combination had little effect on susceptibility to lamivudine. Conclusion: K65R antagonizes the NRTI monophosphate excision activity of RT containing TAMs. TAMs antagonize the ability of K65R RT to discriminate against the nucleotide analog. Therapies including NRTI that select for both TAMs and K65R may prolong treatment response through the mutually antagonistic interactions between these resistance mutations." @default.
• W2002104731 created "2016-06-24" @default.
• W2002104731 creator A5038307269 @default.
• W2002104731 creator A5044933366 @default.
• W2002104731 creator A5084175124 @default.
• W2002104731 creator A5089446248 @default.
• W2002104731 date "2007-07-11" @default.
• W2002104731 modified "2023-10-18" @default.
• W2002104731 title "Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase" @default.
• W2002104731 cites W1511239607 @default.
• W2002104731 cites W1533660032 @default.
• W2002104731 cites W1546361071 @default.
• W2002104731 cites W1601059238 @default.
• W2002104731 cites W1744409238 @default.
• W2002104731 cites W1970893465 @default.
• W2002104731 cites W1973711348 @default.
• W2002104731 cites W1985772041 @default.
• W2002104731 cites W2003037761 @default.
• W2002104731 cites W2007284161 @default.
• W2002104731 cites W2010959307 @default.
• W2002104731 cites W2014890179 @default.
• W2002104731 cites W2015939102 @default.
• W2002104731 cites W2016818354 @default.
• W2002104731 cites W2019538762 @default.
• W2002104731 cites W2023942953 @default.
• W2002104731 cites W2024731636 @default.
• W2002104731 cites W2027772558 @default.
• W2002104731 cites W2033978085 @default.
• W2002104731 cites W2035938088 @default.
• W2002104731 cites W2041282028 @default.
• W2002104731 cites W2045092579 @default.
• W2002104731 cites W2051754694 @default.
• W2002104731 cites W2052200516 @default.
• W2002104731 cites W2099789127 @default.
• W2002104731 cites W2103737563 @default.
• W2002104731 cites W2123210495 @default.
• W2002104731 cites W2123884405 @default.
• W2002104731 cites W2135124387 @default.
• W2002104731 cites W2135450624 @default.
• W2002104731 cites W2137698258 @default.
• W2002104731 cites W2146381501 @default.
• W2002104731 cites W2150487989 @default.
• W2002104731 cites W2151989745 @default.
• W2002104731 cites W2165473677 @default.
• W2002104731 cites W2168836088 @default.
• W2002104731 cites W2168910994 @default.
• W2002104731 cites W2315489356 @default.
• W2002104731 doi "https://doi.org/10.1097/qad.0b013e3281ac229b" @default.
• W2002104731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17589186" @default.
• W2002104731 hasPublicationYear "2007" @default.
• W2002104731 type Work @default.
• W2002104731 sameAs 2002104731 @default.
• W2002104731 citedByCount "83" @default.
• W2002104731 countsByYear W20021047312012 @default.
• W2002104731 countsByYear W20021047312013 @default.
• W2002104731 countsByYear W20021047312014 @default.
• W2002104731 countsByYear W20021047312015 @default.
• W2002104731 countsByYear W20021047312016 @default.
• W2002104731 countsByYear W20021047312017 @default.
• W2002104731 countsByYear W20021047312019 @default.
• W2002104731 countsByYear W20021047312020 @default.
• W2002104731 countsByYear W20021047312021 @default.
• W2002104731 countsByYear W20021047312022 @default.
• W2002104731 countsByYear W20021047312023 @default.
• W2002104731 crossrefType "journal-article" @default.
• W2002104731 hasAuthorship W2002104731A5038307269 @default.
• W2002104731 hasAuthorship W2002104731A5044933366 @default.
• W2002104731 hasAuthorship W2002104731A5084175124 @default.
• W2002104731 hasAuthorship W2002104731A5089446248 @default.
• W2002104731 hasBestOaLocation W20021047311 @default.
• W2002104731 hasConcept C104317684 @default.
• W2002104731 hasConcept C153574943 @default.
• W2002104731 hasConcept C153911025 @default.
• W2002104731 hasConcept C156719811 @default.
• W2002104731 hasConcept C159047783 @default.
• W2002104731 hasConcept C170493617 @default.
• W2002104731 hasConcept C185592680 @default.
• W2002104731 hasConcept C2522874641 @default.
• W2002104731 hasConcept C2777108182 @default.
• W2002104731 hasConcept C2777351918 @default.
• W2002104731 hasConcept C2777383412 @default.
• W2002104731 hasConcept C2777869810 @default.
• W2002104731 hasConcept C2780216070 @default.
• W2002104731 hasConcept C2780593183 @default.
• W2002104731 hasConcept C2780727368 @default.
• W2002104731 hasConcept C2909970146 @default.
• W2002104731 hasConcept C3013748606 @default.
• W2002104731 hasConcept C49105822 @default.
• W2002104731 hasConcept C512185932 @default.
• W2002104731 hasConcept C552990157 @default.
• W2002104731 hasConcept C55493867 @default.
• W2002104731 hasConcept C67705224 @default.
• W2002104731 hasConcept C86803240 @default.
• W2002104731 hasConceptScore W2002104731C104317684 @default.
• W2002104731 hasConceptScore W2002104731C153574943 @default.
• W2002104731 hasConceptScore W2002104731C153911025 @default.
• W2002104731 hasConceptScore W2002104731C156719811 @default.
• W2002104731 hasConceptScore W2002104731C159047783 @default.

• next